ArticleJournal of assisted reproduction and genetics2026
The impact of prior hormonal intrauterine device (IUD) use on endometrial lining thickness in the fertility clinic setting: a retrospective cohort study.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDespite wide-spread use of intrauterine devices (IUDs), research on an IUD's long-term impact on endometrial growth and function is limited. Endometrial atrophy is a known mechanistic action of hormonal IUDs, and characterizing its reversibility is critical. Our study compared endometrial lining thickness (EMT) in patients undergoing fertility treatment with and without prior hormonal IUD use.
methodsThis was a retrospective cohort study of 163 patients aged 18-45, each with at least 1 treatment cycle with ultrasound monitoring at a single academic institution between 2018 and 2023. Patients with prior hormonal IUD use (n = 72) were compared with patients without prior IUD exposure (n = 91). Primary outcomes included mid-cycle endometrial thickness (EMT) in the first monitored cycle, thin lining (< 7 mm), and persistently thin lining (< 7 mm in ≥ 2 cycles). Secondary outcomes included trilaminar endometrial pattern. Multivariable regression models adjusted for age, BMI, parity, infertility diagnosis, uterine pathology, history of uterine procedures, miscarriage history, and treatment protocol type. Exploratory analyses evaluated duration of hormonal IUD exposure.
resultsMedian EMT in the first monitored cycle was significantly lower among patients with prior hormonal IUD exposure compared with patients without prior IUD exposure (6.70 mm vs 8.60 mm, p < 0.001). Thin endometrium in the first cycle occurred in 63% of HORMONAL IUD users versus 16% of controls (RR 3.79, 95% CI 2.31-6.23, p < 0.001). Among patients with multiple cycles, persistently thin lining occurred in 64% of hormonal IUD users versus 10% of controls (RR 6.32, 95% CI 3.05-13.13, p < 0.001). In multivariable analyses, prior hormonal IUD exposure remained associated with thinner EMT in the first cycle (adjusted mean difference - 1.9 mm, 95% CI - 2.6 to - 1.2, p < 0.01) and increased risk of thin lining (adjusted RR 4.09, p < 0.01). Cycle-level analyses similarly demonstrated thinner endometrium and higher rates of thin lining among hormonal IUD users after adjustment for treatment protocol type. Longer duration of hormonal IUD use was not significantly associated with greater risk of thin lining.
conclusionsPrior hormonal IUD use was significantly associated with thinner EMT in patients undergoing fertility treatment. While thinner lining after IUD use is concerning in this specific population, future prospective studies are needed to evaluate the clinically relevant outcomes of live birth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.